Article

Mercury and autism: Accelerating evidence?

Institute for Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Germany.
Neuro endocrinology letters (Impact Factor: 0.94). 11/2005; 26(5):439-46.
Source: PubMed

ABSTRACT The causes of autism and neurodevelopmental disorders are unknown. Genetic and environmental risk factors seem to be involved. Because of an observed increase in autism in the last decades, which parallels cumulative mercury exposure, it was proposed that autism may be in part caused by mercury. We review the evidence for this proposal. Several epidemiological studies failed to find a correlation between mercury exposure through thimerosal, a preservative used in vaccines, and the risk of autism. Recently, it was found that autistic children had a higher mercury exposure during pregnancy due to maternal dental amalgam and thimerosal-containing immunoglobulin shots. It was hypothesized that children with autism have a decreased detoxification capacity due to genetic polymorphism. In vitro, mercury and thimerosal in levels found several days after vaccination inhibit methionine synthetase (MS) by 50%. Normal function of MS is crucial in biochemical steps necessary for brain development, attention and production of glutathione, an important antioxidative and detoxifying agent. Repetitive doses of thimerosal leads to neurobehavioral deteriorations in autoimmune susceptible mice, increased oxidative stress and decreased intracellular levels of glutathione in vitro. Subsequently, autistic children have significantly decreased level of reduced glutathione. Promising treatments of autism involve detoxification of mercury, and supplementation of deficient metabolites.

Download full-text

Full-text

Available from: Harald Walach, Jul 07, 2015
0 Followers
 · 
233 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many factors have been implicated in the onset of autism, including excess or deficiency in toxic or essential metals and impaired antioxidant systems. Exposure to metals is a putative risk factor for autism. Many metals can be implicated in autism as they typically disrupt enzyme functions and cell signaling processes and generate oxygen free radicals (ROS). Patients and methods Thirty-two autistic patients ranging in age from 2.6 to 12.7 years (mean age 5.6 years) were examined clinically. Twenty healthy children matched for age and sex were included as a control group. Serum mercury, lead, and nitric oxide were estimated in all patients. Results Eighteen patients presented with seizures and an epileptogenic focus in the electroencephalogram. The intelligent quotient assessment showed mental retardation in all patients: 18 had moderate retardation, two had severe retardation, and 12 had profound retardation. Assessment of the severity of autistic symptoms using the childhood autism rating scale indicated that six patients had mild, 12 had moderate, and 14 had severe autistic symptoms. The estimation of the level of mercury and lead in blood showed a significant increase compared with the control group (P= 0.0001). Furthermore, nitric oxide was significantly increased compared with the control group (P = 0.0001). These findings indicated a significant increase in both metal content and an imbalance in the oxidative status in the blood of autistic children. Conclusion Our findings suggest the hypothesis that exposure to metals and oxidative stress may be biomarkers of toxicity in autism. We recommend the consideration of supplementing autistic patients with antioxidants. We also recommend the study of introducing chelating agents for mercury and lead in patients with high toxic levels and their effect on clinical symptoms.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Many factors have been implicated in autism onset, including excess or deficiency in toxic or essential metals and impaired antioxidant systems. Exposure to metals is a putative risk factor for autism. Many metals could be implicated in autism since they typically disrupt enzyme functions and cell signaling processes and generate oxygen free radicals (ROS). Patients and Methods: Thirty two autistic patients whose age ranged from 2.6-12.7 years (mean age 5.6 years) were clinically examined. Twenty healthy children matching age and gender were taken as a control group. Serum mercury, lead and nitric oxide were estimated in all patients. Results: Eighteen presented with seizures and epileptogenic focus in electro-encephalogram (EEG). The IQ assessment showed mental retardation in all patients: 18 were moderate, 2 were severe and 12 were profound. Assessments of the severity of autistic symptoms using childhood autism rating scale (CARS), 6 patients were mild, 12 were moderate and 14 were severe. The estimation of the level of mercury and lead in blood showed significant increase compared to control group (P value 0.0001). Furthermore, nitric oxide was significantly increased than the control group (P value 0.0001). These findings demonstrate a significant increase in both metal content and an imbalance in the oxidative status in the blood of autistic children. Conclusion: Our findings suggest the hypothesis that exposure to metals and oxidative stress may be biomarkers of toxicity in autism. We suggest the consideration of supplementing autistic patients with antioxidants. We also recommend the study of introducing chelating agents for mercury and lead in patients with toxic levels and their effect on clinical symptoms.
    01/2012; DOI:10.1097/01.MXE.0000422775.82611.a3
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An association between autism and early life exposure to mercury is a hotly debated issue. In this study, 91 autistic Polish children, male and female, 3-4 and 7-9 years old, were compared to 75 age- and sex-matched healthy children with respect to: demographic, perinatal, clinical and developmental measures, parental age, birth order, morphometric measures, vaccination history, and hair mercury content. In demographic and perinatal measures there were no consistent differences between the autistic and control groups. Autistic children had a significantly greater prevalence of adverse reactions after vaccinations and abnormal development than controls. Between 45 and 80% of autistic children experienced developmental regress. Autistic children significantly differed from healthy peers in the concentrations of mercury in hair: younger autistics had lower levels, while older - higher levels than their respective controls. The results suggest that autistic children differ from healthy children in metabolism of mercury, which seems to change with age.
    Acta neurobiologiae experimentalis 01/2010; 70(2):196-208. · 2.24 Impact Factor